Method of treatment of cancers
US-12036259-B2 · Jul 16, 2024 · US
US12115204B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12115204-B2 |
| Application number | US-202117790646-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 5, 2021 |
| Priority date | Jul 20, 2020 |
| Publication date | Oct 15, 2024 |
| Grant date | Oct 15, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed are a compound preparation for neuranagenesis, and a preparation method therefor and the use thereof. The compound preparation for neuranagenesis comprises the raw medicinal materials in parts by weight: 10-20 parts of raw Astragali radix , 10-20 parts of Rehmaimiae Radix praeparata , 10-20 parts of Actyranthes bidentata , 6-15 parts of Jujubae fructus , 6-15 parts of Lycii fructus , 6-15 parts of parched Ziziphi spinosae semen, 6-12 parts of Angelicae smensis radix , 3-9 parts of Carthami flos , 6-15 parts of Poria , 6-15 parts of parched Atractylodis macrocephalae rhizoma and 10-20 parts of Zaocys . The compound preparation can be used for preparing drugs to treat nerve damage diseases, and can be prepared into oral liquids, granules, dissolved granules and tablets.
Opening claim text (preview).
What is claimed is: 1. A compound preparation for neuranagenesis, wherein the compound preparation comprises the raw medicinal materials in parts by weight: 10-20 parts of raw Astragali radix, 10-20 parts of Rehmanniae Radix praeparata, 10-20 parts of Achyranthes bidentata, 6-15 parts of Jujubae fructus, 6-15 parts of Lycii fructus, 6-15 parts of parched Ziziphi spinosae semen, 6-12 parts of Angelicae sinensis radix, 3-9 parts of Carthami flos, 6-15 parts of Poria, 6-15 parts of parched Atractylodis macrocephalae rhizoma and 10-20 parts of Zaocys , and the dosage form of the compound preparation for neuranagenesis comprises oral liquid prepared by: soaking the raw materials in deionized water at 25° C. for 120 min; performing water extraction, and decocting at 100° C. for 20 min; taking the decoction and allowing same to stand at 4° C. for 12 h under sterile conditions, performing filtration and concentration, and adding benzoic acid or sodium benzoate; and performing filling and sterilization to obtain the oral liquid. 2. The compound preparation for neuranagenesis according to claim 1 , wherein the compound preparation comprises the raw medicinal materials in parts by weight: 15 parts of raw Astragali radix, 15 parts of Rehmanniae Radix praeparata, 15 parts of Achyranthes bidentata, 10 parts of Jujubae fructus, 10 parts of Lycii fructus, 10 parts of parched Ziziphi spinosae semen, 6 parts of Angelicae sinensis radix, 3 parts of Carthami flos, 10 parts of Poria, 10 parts of parched Atractylodis macrocephalae rhizoma and 15 parts of Zaocys. 3. The compound preparation for neuranagenesis according to claim 2 , wherein the compound preparation also comprises an effective dose of the formulation components of the compound preparation and pharmaceutically acceptable excipients. 4. A method for preparing the compound preparation for neuranagenesis according to claim 3 , wherein when the dosage form of the compound preparation is oral liquid, the preparation method further comprises the following step: preparing raw materials in parts by weight: 15 parts of raw Astragali radix, 10 parts of Jujubae fructus, 15 parts of Rehmanniae Radix praeparata, 10 parts of Lycii fructus, 15 parts of Achyranthes bidentata, 10 parts of parched Ziziphi spinosae semen, 6 parts of Angelicae sinensis radix, 3 parts of Carthami flos, 10 parts of Poria, 10 parts of parched Atractylodis macrocephalae rhizoma and 15 parts of Zaocys , and rinsing the medicinal materials with water to remove impurities. 5. A method for preparing the compound preparation for neuranagenesis according to claim 3 , wherein when the dosage form of the compound preparation is granules, the preparation method further comprises the following step: preparing raw materials in parts by weight: 15 parts of raw Astragali radix, 10 parts of Jujubae fructus, 15 parts of Rehmanniae Radix praeparata, 10 parts of Lycii fructus, 15 parts of Achyranthes bidentata, 10 parts of parched Ziziphi spinosae semen, 6 parts of Angelicae sinensis radix, 3 parts of Carthami flos, 10 parts of Poria, 10 parts of parched Atractylodis macrocephalae rhizoma and 15 parts of Zaocys , and rinsing the medicinal materials with water to remove impurities. 6. A method of treating nerve damage diseases comprising administering a therapeutically effective amount of the compound preparation for neuranagenesis according to claim 1 . 7. A compound preparation for neuranagenesis, wherein the compound preparation comprises the raw medicinal materials in granules: 15 parts of raw Astragali radix, 10 parts of Jujubae fructus, 15 parts of Rehmanniae Radix praeparata, 10 parts of Lycii fructus, 15 parts of Achyranthes bidentata, 10 parts of parched Ziziphi spinosae semen, 6 parts of Angelicae sinensis radix, 3 parts of Carthami flos, 10 parts of Poria, 10 parts of parched Atractylodis macrocephalae rhizoma and 15 parts of Zaocys , and rinsing the medicinal materials with water to remove impurities, and the dosage form of the compound preparation for neuranagenesis comprises granules prepared by: soaking the raw materials in deionized water at 25° C. for 120 min; performing water extraction, and decocting at 100° ° C. for 20 min; taking the decoction and allowing same to stand at 4° C. for 12 h under sterile conditions, performing filtration and concentration, and adding benzoic acid or sodium benzoate; and performing drying, granulation, filling and sterilization to obtain the granules.
Snakes; Lizards, e.g. chameleons (therapeutic use of a snake venom protein A61K38/00) · CPC title
Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying · CPC title
using water, e.g. cold water, infusion, tea, steam distillation or decoction · CPC title
involving cleaning, e.g. washing or peeling · CPC title
Lycium (desert-thorn) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.